🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
1,179

Quick answer

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. TAK-935 Tablets

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. TAK-951

    Takeda

    Nausea and Vomitting

    phase 1 small molecule terminated

    1 trial

  3. TAK-951

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  4. TAK-951

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  5. TAK-951 Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. TAK-954

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  7. TAK-954

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  8. TAK-954

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  9. TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. TAK-981

    Takeda

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  11. TAK-988

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  12. TAK-994

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  13. TAK-994

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    2 trials

  14. TAK-994 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. TAKC-02

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  16. TBio-6517

    Takeda

    Solid Tumor

    phase 1 mab terminated

    1 trial

  17. TDV - Low Dose

    Takeda

    Dengue Fever

    phase 1 mab completed

    1 trial

  18. Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

    Takeda

    Healthy

    phase 1 mab completed

    1 trial

  19. Teduglutide

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. Teduglutide

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  21. Trebananib 3 mg/kg

    Takeda

    Neoplasms, Advanced Solid

    phase 1 small molecule completed

    1 trial

  22. VP 20629

    Takeda

    Friedreich's Ataxia

    phase 1 small molecule completed

    1 trial

  23. Vedolizumab SC

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  24. Vedolizumab SC

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    4 trials

  25. Vortioxetine

    Takeda

    Severe Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  26. Vortioxetine

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  27. Vortioxetine

    Takeda

    Healthy Adult Participants

    phase 1 small molecule completed

    1 trial

  28. Zasocitinib

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  29. [14C] Subasumstat

    Takeda

    Solid Tumors

    phase 1 small molecule terminated

    1 trial

  30. [14C]-TAK-385 Oral Solution

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  31. [14C]-TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  32. [68Ga]MLN6907

    Takeda

    Imaging of Solid Gastrointestinal Tumors

    phase 1 small molecule completed

    1 trial

  33. [^14C]-alisertib

    Takeda

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  34. alisertib

    Takeda

    Advanced Malignancies

    phase 1 small molecule completed

    2 trials

  35. alisertib

    Takeda

    Acinar Cell Adenocarcinoma of the Pancreas

    phase 1 small molecule completed

    1 trial

  36. eASC

    Takeda

    Localized Adverse Reaction to Administration of Drug

    phase 1 gene therapy completed

    1 trial

  37. immediate release guanfacine hydrochloride

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  38. lumbar puncture

    Takeda

    Crohn's Disease

    phase 1 small molecule completed

    1 trial

  39. namilumab (MT203)

    Takeda

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial

  40. placebo control

    Takeda

    Hemophilia

    phase 1 small molecule terminated

    1 trial

  41. rhASA - Dose Level 1

    Takeda

    Metachromatic Leukodystrophy (MLD)

    phase 1 mab completed

    1 trial

  42. rhPTH(1-84)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  43. sulfamethoxazole + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  44. teduglutide

    Takeda

    Pharmacokinetics and Safety of Elevated Doses

    phase 1 small molecule completed

    1 trial

  45. "Nycoplus Magnesium" (120 mg x 3 daily for 2 weeks)

    Takeda

    Cramps

    approved small molecule completed

    1 trial

  46. 1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

    Takeda

    Prostate or Bladder Cancer

    approved small molecule completed

    1 trial

  47. 1-84 parathyroid hormone

    Takeda

    Shoulder Fractures

    approved small molecule active

    1 trial

  48. AD-4833 15 mg

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.